Rückerl Dominik, Hessmann Manuela, Yoshimoto Takayuki, Ehlers Stefan, Hölscher Christoph
Junior Research Group Molecular Infection Biology, Research Center Borstel, Parkallee 22, D-23845 Borstel, Germany.
Immunobiology. 2006;211(6-8):427-36. doi: 10.1016/j.imbio.2006.05.008. Epub 2006 Jul 5.
The interleukin (IL)-27 receptor-alpha WSX-1 is one component of the heterodimeric IL-27 receptor that is expressed on various cell types including macrophages. We previously demonstrated that IL-27 induces STAT-3 and is able to inhibit the production of pro-inflammatory cytokines in activated macrophages suggesting a novel feed-back mechanism by which IL-27 can modulate excessive inflammation. Because IL-4 receptor-alpha (IL-4Ralpha)-induced alternatively activated macrophages have also been described to attenuate pathological inflammatory immune responses, we analyzed the contribution of IL-27 in alternative macrophage activation. In the present study, like IL-10 and IL-4, IL-27 was found to suppress IL-12/23p40 production in activated bone marrow-derived macrophages. Whereas IL-10 induced the upregulation of the IL-4Ralpha on macrophages, receptor expression was not triggered by IL-27. In contrast to IL-4, IL-27 did not induce alternative macrophage activation but IL-4 strongly upregulated the expression of WSX-1 on macrophages and alternative macrophage activation enhanced IL-27-mediated signalling. We therefore conclude from our study that IL-10, IL-4 and IL-27 collaborate in modulating macrophage activation by successive upregulation of the IL-4Ralpha and WSX-1 on alternatively activated macrophages.
白细胞介素(IL)-27受体α链WSX-1是异二聚体IL-27受体的一个组成部分,在包括巨噬细胞在内的多种细胞类型上表达。我们之前证明IL-27可诱导信号转导和转录激活因子3(STAT-3),并能够抑制活化巨噬细胞中促炎细胞因子的产生,提示存在一种新的反馈机制,通过该机制IL-27可调节过度炎症。由于白细胞介素4受体α链(IL-4Rα)诱导的替代性活化巨噬细胞也被描述为可减轻病理性炎症免疫反应,我们分析了IL-27在替代性巨噬细胞活化中的作用。在本研究中,与白细胞介素10(IL-10)和IL-4一样,发现IL-27可抑制活化的骨髓来源巨噬细胞中IL-12/23p40的产生。虽然IL-10可诱导巨噬细胞上IL-4Rα的上调,但IL-27不会触发受体表达。与IL-4不同,IL-27不会诱导替代性巨噬细胞活化,但IL-4可强烈上调巨噬细胞上WSX-1的表达,且替代性巨噬细胞活化可增强IL-27介导的信号传导。因此,我们从研究中得出结论,IL-10、IL-4和IL-27通过在替代性活化巨噬细胞上依次上调IL-4Rα和WSX-1来协同调节巨噬细胞活化。